This PA will focus on techniques and technologies leading to improved chemical synthesis and delivery of RNAi, particularly those incorporating chemical modifications that change the properties of the siRNA molecules to increase their stability and their ability to be delivered more efficiently to target cells without increasing their toxicity. This PA is intended to support innovative research in the field of RNAi synthesis and delivery to defined target sites, conducted by small business concerns (SBIR).